Table 3

Cases of black women meeting obstetric haemorrhage criteria by site from July 2020 to June 2021

Site 1
N=91
Site 2
N=66
Site 3
N=6
Site 4
N=5
Site 5
N=4
P value
Baseline and labour and delivery characteristics
Insured through Medicaid66 (73.3)45 (70.3)5 (83.3)2 (40.0)1 (25.0)0.20
Age*28 (23–34)29 (26–32)31 (29–31)24 (22–24)30 (27–34)0.31
BMI at admission†35.4 (8.1)33.8 (7.4)32.9 (4.8)32.4 (9.4)27.1 (8.1)0.89
Anaemia (Hb <110 g/L) during pregnancy43 (48.3)40 (60.6)3 (50.0)2 (40.0)3 (75.0)0.47
Utilisation of intravenous iron during pregnancy‡11 (25.6)14 (35.0)0000.27
Labour type0.053
 Induction47 (52.1)24 (36.9)3 (50.0)02 (50.0)
 Spontaneous labour32 (36.0)25 (38.5)1 (16.7)4 (80.0)1 (25.0)
 No labour (scheduled caesarean)10 (11.2)16 (24.6)2 (33.3)1 (20.0)1 (25.0)
Mode of delivery0.90
 Vaginal delivery66 (74.1)44 (67.7)4 (66.7)4 (80.0)3 (75.0)
 Caesarean delivery23 (25.8)21 (32.3)2 (33.3)1 (20.0)1 (25.0)
 Estimated blood loss (cc)*1200 (800–1500)1360 (950–2000)1010 (810–1250)900 (200–1000)1450 (1125–2000)0.03
Management of haemorrhage
Uterotonic utilisation§
 Methylergonovine29 (31.9)20 (30.3)1 (16.7)1 (20.0)00.80
 Carboprost22 (24.2)24 (36.4)1 (16.7)02 (50.0)0.18
 Misoprostol43 (47.3)46 (69.7)3 (50.0)2 (40.0)2 (50.0)0.048
 Tranexamic acid1 (1.1)19 (28.8)002 (50.0)<0.001
Balloon tamponade utilisation11 (12.1)13 (19.7)0000.53
B-lynch suture utilisation1 (1.1)00001.00
Uterine artery embolisation1 (1.1)00001.00
Packed red blood cell transfusion utilisation30 (33.0)26 (39.4)3 (50.0)1 (20.0)1 (25.0)0.76
  • This table includes demographic and clinical characteristics, labour and delivery outcomes including details of obstetric haemorrhage as well as management modalities.

  • *Results are shown as n (%) except where indicated median (IQR).

  • †Mean (SD).

  • ‡Among those with anaemia.

  • §Could use more than one.

  • BMI, body mass index.